This study is currently not recruiting participants.

Evaluation of the Use of the Tissue Genesis? Icellator Cell Isolation System? for Autologous Adipose-Derived Stromal Vascular Fraction Cells to Treat Critical Limb Ischemia

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

The purpose of this study is to assess the initial safety and feasibility of treatment with the Tissue Genesis (TGI) Icellator. This device removes certain cells from the fatty tissue which will be used to treat patients with poor blood flow in the leg caused by peripheral artery disease (PAD).

Description

The purpose of this study is to assess the initial safety and preliminary feasibility of treatment with the Tissue Genesis (TGI) Icellator Cell Isolation System (Icellator) to prevent or delay major amputation and/or death in subjects with critical limb ischemia (CLI).

Details
Condition Peripheral Artery Disease
Age 21years - 100years
Clinical Study IdentifierTX3745
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.